Severe Refractory Hypocalcemia After Administering Zoledronic Acid for Osteoporotic Fracture in Primary Hyperparathyroidism That Is Complicated Into Hungry Bone Syndrome: A Case Report

Zoledronic acid is a very effective (IV) amino bisphosphonate which is indicated in osteoporosis, hypercalcemia of malignancy, multiple myeloma, Paget’s disease, and bone metastases from solid tumors. Bisphosphonate inhibits bone resorption through actions on osteoclast activity resulting in increas...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Endocr Soc
मुख्य लेखकों: Alhamdan, Ali Saleh, Douba, Najah Younes, Aljamaan, Abdulaziz, Alghamdi, Abdulrahman Aidh, Alhammad, Zahrah Abbas, Alanazi, Khalid
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2021
विषय:
Bone and Mineral Metabolism
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089785/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.450
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन